1. Antiarrhythmic Drugs: Atropine speeds shit up. Adenosine slows it down. Amiodarone fixes anything, but kills your lungs. Everything else is 6th line.
2. Antipsychotic Drugs: All that’s worth knowing about the 2nd gens are their major side-effects, which luckily mirror their names: Olanzapine causes weight gain cause “o” is the fattest letter. Aripiprazole and Ziprasidone sound zippy and thin, and are both weight-neutral. (Ziprasidone is, in fact, so zippy that it can cause arrhythmias). And finally, Quetiapine sounds like “quiet”, which is appropriate because it has the quietest side-effect profile (the least risk of extrapyradimal S/Es or increased prolactin).
3: Sensitivity of a test vs its Positive Predictive Value: Tricky because they seem so similar, so the temptation is to think of them as the same exact thing. Textbooks do a crappy job of explaining the difference, I think, so here’s my attempt at it:
Say your friend makes an instant swab test for The Bubonic Plague. The test correctly catches all but 1% of her PI’s Yersinia Pestis Orientalis samples at the expense of also catching 5% of the perfectly healthy controls- so her screening test is 99% sensitive and 95% specific. You are impressed.
She swabs your cheek with it to while she’s explaining the test to you. If the test then gives a positive result, how worried about imminent death would you really be?
Answer: you shouldn’t be worried at all, because The Bubonic Plague is so rare that the odds of you being one of the 5% false positives vastly eclipses the chance you are the index case of a modern pandemic.
So despite being an extremely sensitive test, it has a low PPV… in the modern population. The key point is that if you were a medieval European peasant getting that same swab and testing positive, you’d correctly be far, far more worried. The Positive Predictive Value of the exact same test would be higher in the 14th century.
And that’s the point: sensitivity & specificity depend only on the test, whereas PPV and NPV also depend on the prevalence of the disease of the population being screened.